Mothers Working to Prevent Early Stillbirth Study 20-28
Recruiting
Observational Study
Stillbirth and Fetal Death
Perinatal Death
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 – 50
- Sex
- Female
- Study type
- Observational
- Participants needed
- 948 (estimated)
- Sponsor
- University of Manchester · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This project aims to identify factors linked to pregnancy losses occurring between 20 and 28 weeks of pregnancy that can be modified by changing mother's behaviour or healthcare provision.
The death of a child before birth (also called stillbirth or miscarriage) has enduring psychological, social and economic effects for women, their families and wider society. In 2015, the stillbirth rate in the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Cases
* Bereaved mothers/parents who have recently birthed a singleton baby who died before/during or immediately after labour between 20 and 28 weeks of pregnancy.
* Baby has no evidence of congenital anomaly
* Able to give written informed consent
Controls
* Pregnant women/people with an ongoin…
Contacts